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Hypocortisolism is an uncommon condition. Its association with myopathy and respiratory failure has
only rarely been described. We report the case of a 52 year-old woman presenting with progressive
dyspnoea. Work-up revealed a severe restrictive syndrome with hypoxaemia. Further investigations
showed hypocortisolism of pituitary origin. Response to hydrocortisone allowed us to conclude to an
unusual case of hypocortisolic myopathy affecting the respiratory muscles.
 2011 Elsevier Ltd. All rights reserved.Educational aims
 To stimulate awareness of the potential impact of an acquired
myopathy on respiratory function.
 To stimulate awareness of the potential impact of endocrine
diseases on respiratory muscles.
 To incite caution in the prescription and withdrawal of corti-
coid therapy in patients with a history of pituitary surgery.
 To promote screening of subclinical myopathies in patients
with borderline respiratory function in an attempt to ﬁnd
curable causes of respiratory deterioration.1. Case report
A 52 year-old woman was hospitalized with progressive grade
III dyspnoea. The disorder began as a dry cough that became
productive with yellow sputum ten days prior to admission. Over
the past 8 months, she had presented vomiting, weight loss,
asthenia and anorexia.
Her clinical history revealed trans-sphenoidal surgery for a large
intra-sellar arachnoid cyst, hypothyroidism due to Hashimoto
thyroiditis, mild type 2 diabetes mellitus, and arterial hypertension.; CT, computed tomography;
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rved.The patient was a non-smoker and had never suffered from
a respiratory or atopic disease.
Her medication included levothyroxine, metformin (850 mg 3x/
day), bumetanide (5 mg/day) and a combined pill with 10 mg of
bisoprolol and 25 mg of hydrochlorothiazide for hypertension.
Clinical examination revealed no pyrexia. Blood pressure was
150/50 mmHg and heart rate averaged 104 beats per minute.
Haemoglobin saturation without oxygen supplementation reached
92% and respiratory frequency was 20 per minute. Cardiac
auscultation was normal. Auscultation of the lungs disclosed
symmetrical ventilation with bilateral posterior-basal crackles.
Baseline blood tests (Table 1) showed hyponatraemia, hypo-
kalaemia and an inﬂammatory syndrome with hyperleukocytosis.
Arterial blood gases underlined severe hypoxia (PaO2 56 mmHg)
associated with moderate hypercapnia (PaCO2 48.8 mmHg). The
chest radiograph was normal. However, thoracic CT-scan outlined
multiple ground glass inﬁltrates of pseudo-nodular aspect, mainly
in the sub-cortical regions of the middle and lower right lobes.
Cardiac evaluation (ECG, trans-thoracic echocardiography and
stress echocardiography) was normal. Ventilationeperfusion scin-
tigraphy excluded a pulmonary embolism. Bronchoscopy, broncho-
alveolar lavage and tracheo-bronchial aspiration did not provide
any valuable information. Pulmonary function tests demonstrated
a restrictive syndrome (total lung capacity: 65% of predicted values)
with normal alveolar-capillary diffusion. Ergospirometry disclosed
major fatigue in the lower limb muscles and arterial oxygen desa-
turation. Lastly, after six days with antibiotic therapy, a thoracic
CT-scan showed a regression of the inﬁltrates.
To exclude a neuromuscular disease electromyography (EMG) of
the lower limbs was performed but was absolutely normal. Muscle
Table 1
Comparison of laboratory parameters before and after hydrocortisone therapy.
Normal values Before hydrocortisone After hydrocortisone
Natremia 135e145 mmol/L 130 145
Kalemia 3.1e4.9 mmol/L 2.8 4.6
pH 7.35e7.45 7.53 7.51
pCO2 35.0e43.0 mmHg 48.8 43.0
PO2 65e100 mmHg 56 95
TSH 0.20e4.20 mIU/mL 0.11 0.53
Free T3 1.5e4.6 pg/mL 1.9 2.3
Fig. 1. Biopsy slides (Optical microscopy x50). The histo-enzymologic staining for
ATPase. Type 1 (slow-twitch) ﬁbres appear in a lighter shade than the type 2 (fast-
twitch) ﬁbres.
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the quadriceps and intercostal muscles (Fig. 1) were performed.
They showed a mild amyotrophy of non-speciﬁc aspect, especially
of type II ﬁbres.
The possibility of an endocrine myopathy was brought up given
the non-speciﬁc aspect of the biopsy and other unaccountable
elements. The excision of a supra-sellar arachnoid cyst and recent
clinical presentation suggested adrenal insufﬁciency. Hyper-
kalaemia was probably absent because, in adrenal insufﬁciency of
pituitary origin, aldosterone levels are not lowered like in primary
adrenal insufﬁciency.1 Moreover, vomiting and treatment with both
a loop diuretic and hydrochlorothiazide could explain further
potassium losses. To support this hypothesis, morning cortisolae-
mia (8 am) was measured and proved to be drastically reduced at
34 mg/L (N: 100e250) along with a decreased level of ACTH at
13 ng/L (N: 10e70).
Our diagnosis is an endocrine myopathy due to secondary
hypocortisolism. Our assumption is that, in the context of pituitary
surgery, a late exhaustion of the corticotropic cells was revealed by
an infectious state. This diagnosis was supported by the rapid and
remarkable improvement following hormonal supplementation.
Indeed, the restrictive syndrome and hypoxaemia regressed in only
six days of intravenous hydrocortisone therapy (300 mg/24 h).
After 6 months, total lung capacity had increased to 92%.
2. Discussion
Upon suspicion of a neuromuscular respiratory disease, the
maximal inspiratory and expiratory pressures should be
measured.2,3 Thereafter, the EMGandamusclebiopsyarewarranted
to conﬁrm a muscular disorder.2 Nonetheless, one cannot expect toyield pathognomonic information pertaining to hypocortisolic
myopathy from these investigations. In fact, the diagnosis of endo-
crine myopathy is suggested by a normal EMG and a non-speciﬁc
muscle biopsy. It is however possible to observe an amyotrophy,
especially of type II ﬁbres, on the muscle biopsy.
As to the diagnosis of secondary hypocortisolism, it will be
highly suspected if morning cortisol and ACTH are concomitantly
decreased.4 The insulin tolerance test is the gold standard to
ascertain the diagnosis.4,5
3. Conclusion
This case is an exemplary illustration of the impact of subclinical
endocrine or metabolic disturbances on the respiratory muscles. It
is indeed astonishing to witness the complete reversal of the
syndrome under hydrocortisone therapy. Screening and treatment
of such abnormalities could greatly enhance respiratory muscle
function in patients that suffer from chronic respiratory disease in
whom no other therapeutical options are available.
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Appendix. CME questions
 A normal muscle biopsy and a normal EMG exclude the
possibility of an endocrine myopathy? (False)
 Concomitantly low levels of ACTH and cortisol conﬁrm the
diagnosis of secondary hypocortisolism? (False)
 Hyperkalaemia associated with hyponatraemia, a classic bio-
logical ﬁnding of primary hypoadrenalism, is uncommon in
secondary hypocortisolism because aldosterone secretion is
normal? (True)
 Diagnosis of the contribution of a neuromuscular disorder to
a restrictive syndrome is based on maximal inspiratory and
expiratory pressures? (True)
 The gold standard for the diagnosis of secondary hypo-
cortisolism is the metyrapone test? (False)References
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